|
ATXN7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.20719994795616E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.31539999687669E-08 |
| Normal-vs-Stage2 |
6.92589999795601E-08 |
| Normal-vs-Stage3 |
7.36120053801415E-10 |
| Normal-vs-Stage4 |
4.10330003308701E-09 |
| Stage1-vs-Stage2 |
2.900200E-01 |
| Stage1-vs-Stage3 |
2.248300E-02 |
| Stage1-vs-Stage4 |
9.860100E-02 |
| Stage2-vs-Stage3 |
5.558200E-01 |
| Stage2-vs-Stage4 |
6.437400E-01 |
| Stage3-vs-Stage4 |
9.176200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.26600000482924E-08 |
| Normal-vs-AfricanAmerican |
1.239920E-03 |
| Normal-vs-Asian |
1.94149999965809E-07 |
| Caucasian-vs-AfricanAmerican |
3.498200E-01 |
| Caucasian-vs-Asian |
8.684600E-01 |
| AfricanAmerican-vs-Asian |
3.516800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36359998240232E-09 |
| Normal-vs-Female |
1.79460000193643E-08 |
| Male-vs-Female |
2.177000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.38170000002691E-07 |
| Normal-vs-Age(41-60Yrs) |
2.88320001207154E-09 |
| Normal-vs-Age(61-80Yrs) |
7.50419948403191E-10 |
| Normal-vs-Age(81-100Yrs) |
4.902400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.566000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.307940E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.945800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.612600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.403200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.462800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.398700E-04 |
| Classical-VS-Follicular |
4.440900E-03 |
| Classical-VS-Other |
1.574770E-01 |
| Classical-VS-Normal |
5.14580000054998E-07 |
| Tall-VS-Follicular |
3.672400E-01 |
| Tall-VS-Other |
9.827000E-01 |
| Tall-VS-Normal |
5.09190023478823E-10 |
| Follicular-VS-Other |
6.743600E-01 |
| Follicular-VS-Normal |
2.76010003741334E-09 |
| Other-VS-Normal |
1.77224999999837E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.38629996371264E-09 |
| Normal-vs-N1 |
6.01400000022068E-07 |
| N0-vs-N1 |
3.857600E-01 |
|
|
